Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor Conferences
Details for the events are as follows:
A webcast of the presentation will be available for 90 days beginning at
|Guggenheim 3rd Annual Genomic Medicines and Rare Disease Day|
|Fireside Chat Date:|
|Webcast and Replay Link:||https://kvgo.com/guggenheim/krystal-biotech-inc-march-2022|
A replay of the fireside chat will be available via a link on the
Source: Krystal Biotech, Inc.